2012
DOI: 10.1016/j.jep.2011.12.009
|View full text |Cite
|
Sign up to set email alerts
|

Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: A multicenter double-blinded randomized controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
51
0
1

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
3
1

Relationship

1
9

Authors

Journals

citations
Cited by 62 publications
(52 citation statements)
references
References 46 publications
0
51
0
1
Order By: Relevance
“…Through the synergistic effect of multi-components, multi-channels and multi-targets, it showed significant advantages over a single drug treatments, especially for the treatment of chronic complex, multi-factorial diseases [1], [2]. Compared to western medicine, it has been observed to have lower side effects [3][6]. However, for a long time, due to complex chemical composition, prescription diversity and the lack of an effective research approach, the investigation of active compounds and pharmacological mechanisms of action has encountered great challenges, thus becoming one of the main bottlenecks of modernization and internationalization of TCM.…”
Section: Introductionmentioning
confidence: 99%
“…Through the synergistic effect of multi-components, multi-channels and multi-targets, it showed significant advantages over a single drug treatments, especially for the treatment of chronic complex, multi-factorial diseases [1], [2]. Compared to western medicine, it has been observed to have lower side effects [3][6]. However, for a long time, due to complex chemical composition, prescription diversity and the lack of an effective research approach, the investigation of active compounds and pharmacological mechanisms of action has encountered great challenges, thus becoming one of the main bottlenecks of modernization and internationalization of TCM.…”
Section: Introductionmentioning
confidence: 99%
“…60 These patients received either traditional medicines, benazepril, or a combination of the 2. A composite primary end point of 50% increase in serum creatinine level, ESRD, or death was used.…”
Section: Large Randomized Clinical Trials Of Traditional Medicines Inmentioning
confidence: 99%
“…32 For the patients with CKD stage 3, TCMs can improve estimated glomerular filtration rate (eGFR) and hemoglobin with lower side effects. 33 TCM Hachimi-jio-gan played a protective role in the progression of CRF through the decline in uremic toxins, elevation of antioxidative enzyme activity such as superoxide dismutase and catalase, and amelioration of histopathological lesions in the kidney. 34 Cumulative evidence suggests that some TCMs, including Astragalus and a mixture of Astragalus plus Angelica, Ligusticum, Triptolide, and Rhubarb, show benefits in slowing the progression of CKD.…”
Section: The Role Of Tcms In the Treatment Of Crfmentioning
confidence: 99%